- Report
- April 2026
- 120 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- September 2026
- 180 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- May 2026
- 350 Pages
Global
From €4584EUR$4,949USD£3,826GBP
- Report
- April 2026
- 147 Pages
Global
From €3704EUR$3,999USD£3,091GBP
- Report
- April 2026
- 140 Pages
Global
From €3704EUR$3,999USD£3,091GBP
- Report
- April 2026
- 136 Pages
Global
From €3704EUR$3,999USD£3,091GBP
- Report
- April 2026
- 146 Pages
Global
From €3704EUR$3,999USD£3,091GBP
- Report
- April 2026
- 143 Pages
Global
From €3704EUR$3,999USD£3,091GBP
- Report
- April 2026
- 149 Pages
Global
From €3704EUR$3,999USD£3,091GBP
- Report
- April 2026
- 180 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- September 2026
- 118 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- September 2026
- 140 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- August 2026
- 180 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- July 2026
- 112 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- July 2026
- 120 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- July 2026
- 114 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- July 2026
- 181 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- July 2026
- 70 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- July 2026
- 114 Pages
Global
From €4400EUR$4,750USD£3,672GBP
- Report
- June 2026
- 110 Pages
Global
From €4400EUR$4,750USD£3,672GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more